Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 15/01/2009 Portrait of Prof. Dr. Felicitas Pröls

    Felicitas Pröls – an all-rounder in anatomy

    Plant research molecular developmental biology and cell biology anatomy these are just a few of the fields in which Prof. Dr. Felicitas Pröls from the University of Freiburg has achieved major success. She has also recently begun looking into molecular neurobiology. For me professional diversity is the most important thing and it is also the reason why I am happy with my chosen profession said the researcher.

    https://www.gesundheitsindustrie-bw.de/en/article/news/felicitas-proels-an-all-rounder-in-anatomy
  • Press release - 15/01/2009 Picture of vials in Nycomed's laboratory

    Nycomed strengthens its osteoporosis portfolio

    Nycomed and EffRx today announced a licensing agreement on EffRx' drug EX101 (effervescent alendronate) for the treatment of osteoporosis. Under the agreement, Nycomed will receive the exclusive rights to develop, manufacture and commercialise the effervescent formulation of alendronate for the treatment of osteoporosis in a large number of countries worldwide. EX101 presents a significant enhancement to Nycomed's osteoporosis…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-strengthens-its-osteoporosis-portfolio
  • Article - 14/01/2009 07774_de.jpg

    From old to new – the path to the next generation of antibiotics

    When they were first discovered antibiotics were seen as miracle cures. The perception of antibiotics has not greatly changed since. No other class of drugs has ever been able to double the average life expectancy in such a short time. However there is a huge risk that the success that has been achieved will come to nothing because a growing number of pathogens are becoming resistant to antibiotics.

    https://www.gesundheitsindustrie-bw.de/en/article/news/from-old-to-new-the-path-to-the-next-generation-of-antibiotics
  • Dossier - 14/01/2009 The photo shows a female scientist on the right of a biotechnological production unit.

    Biopharmaceuticals continue their triumphant success

    The first genetically engineered drug entered the market a little over 25 years ago. Since then more than 100 others have been launched. Many of these biopharmaceuticals have an outstanding effect thus revolutionising the therapeutic options available in many medical sectors. Biopharmaceuticals also have a huge economic potential. The huge potential of these innovative drugs and their importance for Germanys pharmaceutical industry is reflected…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/biopharmaceuticals-continue-their-triumphant-success
  • Press release - 14/01/2009 07820_de.jpg

    Hunters of lost treasures

    On 1st December 2008 Prof. Dr. Karl Schmid the first person to hold the F.W. Schnell Foundations endowed professorship for crop biodiversity and breeding informatics started the ball rolling on a unique European-wide project. Schmid and his colleagues are searching gigantic databases in which genetic analyses and plant descriptions are stored for hidden treasures.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hunters-of-lost-treasures
  • Article - 14/01/2009 Prof. Sabine Kloth, expert for materials of animal origin at TÜV SÜD Product Service GmbH

    Strict requirements for the market approval of tissue engineering products

    New regulations for the marketing approval of advanced therapy medicinal products have applied in the EU since December 2008. Prof. Sabine Kloth from TÜV SÜD Product Service GmbH is an expert in materials of animal origin and has been closely following the formulation of the ATMP Regulation.

    https://www.gesundheitsindustrie-bw.de/en/article/news/strict-requirements-for-the-market-approval-of-tissue-engineering-products
  • Press release - 14/01/2009 07818_de.jpg

    Looking for the Achilles’ heel of parasites

    Researchers have identified a hormone that controls whether nematode larvae turn into parasites or not.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/looking-for-the-achilles-heel-of-parasites
  • Press release - 14/01/2009

    IND Approval for CureVac

    CureVac Receives IND Approval from the FDA to start its Phase I/IIa mRNA Vaccine Clinical Trial in Prostate Cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ind-approval-for-curevac
  • Press release - 11/01/2009 Archive photo ( 2006) of Adolf Merckle, founder and owner of the Merckle company empire. Merckle ended his life on 5 January 2009.

    Merckle’s empire collapse leads to sale of ratiopharm

    It was clear that something was amiss in 2008, and now things are clearer: The Ulm-based generics producer ratiopharm is to be sold in order to save the Merckle empire that has run into difficulties in the global financial crisis. Numerous sources report that the pharmaceutical company will not be sold before 2010 due to the current unfavourable market situation. It is not known whether the Merckle group will have to part with other companies in…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/merckle-s-empire-collapse-leads-to-sale-of-ratiopharm
  • Press release - 11/01/2009

    Killing cancer cells with only limited side effects

    A group of clinical researchers at the University Hospital in Ulm has discovered new ways to specifically kill cancer cells with radioactive irradiation while preventing healthy organs from being affected. The researchers have also discovered that this method breaks the chemoresistance of cancer cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/killing-cancer-cells-with-only-limited-side-effects
  • Press release - 11/01/2009

    What have sunscreens got to do with hormones?

    Most people are well aware that sunbathing can have dangerous consequences. In Switzerland the debate concerning the undesirable side effects of sunscreens has been temporarily put on hold but will most likely start up again with the onset of the winter season. Daniel R. Dietrich chair of the Department of Toxicology at the University of Constance gives us more details in the following interview.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-have-sunscreens-got-to-do-with-hormones
  • Press release - 10/01/2009 Two pupils are working in a laboratory

    Supporting equal opportunities for women at universities in Baden-Württemberg

    The Baden-Württemberg government now brings together information regarding equal opportunities as well as “Girls and Technology” projects at the state’s universities on the www.scientifica.de Internet portal.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/supporting-equal-opportunities-for-women-at-universities-in-baden-wuerttemberg
  • Article - 10/01/2009 The photo shows a portait of a woman wearing glasses. The woman has long fair hair and is wearing a red pullover.

    Julia Kirchheiner searches for drugs for individuals

    Drugs for individuals rather than diseases - thats what Julia Kirchheiner from the University of Ulm is striving for. The 37-year-old is one of only a handful German experts working in pharmacogenetics research a field of research that investigates the genetic causes of individual differences in peoples response to drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/news/julia-kirchheiner-searches-for-drugs-for-individuals
  • Article - 09/01/2009 07710_de.jpg

    Kay Diederichs – important insights in the fight against bacterial antibiotics resistance

    Bacteria will always find ways to defend themselves against substances such as antibiotics, thus inhibiting their effect. Many bacteria have pump systems that they use to actively remove antibiotic drugs from the cell. Prof. Kay Diederichs at the University of Constance is working on the elucidation of these mechanisms in order to produce useful information for the development of bacterial pump inhibitors.

    https://www.gesundheitsindustrie-bw.de/en/article/news/kay-diederichs-important-insights-in-the-fight-against-bacterial-antibiotics-resistance
  • Press release - 09/01/2009 Portrait of Dr. Michael Richter, German BioValley/Freiburg Bioregion coordinator

    Richter to succeed Siegenführ

    Dr. Michael Richter is the new German BioValley/Freiburg Bioregion coordinator. He succeeds Dr. Thea Siegenführ who has shaped and skilfully organised the biotechnology landscape on the Upper Rhine for the last 16 years.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/richter-to-succeed-siegenfuehr
  • Press release - 08/01/2009 The photos show green fluorescing "spots" on a black background.

    ILM – Cell biology, molecular biology, histology

    The ILM uses cell biology, molecular biology and histological methods to investigate the effects of photosensitisers and laser irradiation on cells and tissues.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-cell-biology-molecular-biology-histology
  • Press release - 08/01/2009 ILM – Three-dimensional representation of a wound area.

    ILM – 3D measurement technique

    The ILM applies a broad range of different methods to determine the form and shape of objects, including 3D surface acquisition using stripe projection-based imaging, interferometry and optical coherence interferometry (OCT)

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-3d-measurement-technique
  • Press release - 08/01/2009 The schematic shows several lenses. A light beam (red) traverses the lenses.

    ILM – In-line determination of roughness in paper production

    An important parameter for the printability of paper is its microstructure and roughness. Previous approaches used to identify these parameters were limited to individual quality controls in the laboratory; no technology has so far been available for process-integrated sensoring. The ILM has taken on the task of solving this issue.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-in-line-determination-of-roughness-in-paper-production
  • Press release - 08/01/2009 Blue spherical structure against a black background. The blue structure contains 3 pink spots.<br />

    ILM – Molecular cytogenetic diagnostics

    The ILM used multicolour fluorescence in-situ hybridisation for the detection of chromosomal changes in the vein tissue of patients suffering from recurrent varicosis.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-molecular-cytogenetic-diagnostics
  • Press release - 08/01/2009 09551_de.jpg

    ILM – Laser Therapy Centre

    The study carried out by the ILM investigates the fractional irradiation of wrinkles and scars using an Erbium:YAG handpiece.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-laser-therapy-centre
  • Press release - 08/01/2009 Spectroscopic substance control: hypercin samples from two manufacturers (A and B) are tested for differences in the absorption and emission spectra.

    ILM – Spectroscopic characterisation of substances

    The optical characterisation of materials through transmission, absorption and reflection is only complete when these values can also be indicated in dependence of the wavelength. In order to investigate these wavelength dependencies, the ILM has a number of high-quality spectrometers available that cover the entire range from ultraviolet to infrared light.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-spectroscopic-characterisation-of-substances
  • Press release - 08/01/2009 The photo shows a yellow-green figure against a black background.

    ILM – Radiobiology and biological dosimetry II

    Lasers, in particular holmium-Yag and dye lasers are being used to an increasing extent in urology to destroy kidney stones. In order to obtain a better understanding of the mechanism of action, detailed investigations were carried out in cooperation with the Laser Centre in Munich.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-radiobiology-and-biological-dosimetry-ii
  • Press release - 08/01/2009 The photo shows an open wound that releases ichor.

    ILM – Laser-assisted diagnosis and therapy method for chronic wounds

    The goal of the cooperative project of the Competence Centre for Minimally Invasive Medicine & Technology Tübingen-Tuttlingen (MITT) and the University Hospital of Tübingen was to facilitate the treatment of chronic wounds and improve their healing process using an innovative laser method. The partners developed a method that enables the recognition of necrotic tissue on wound surfaces and the contact-free ablation of the tissue using a…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-laser-assisted-diagnosis-and-therapy-method-for-chronic-wounds
  • Press release - 08/01/2009 Two pictures: The picture on the left shows a fluorescence-labelled antibody; yellow liquid is withdrawn with a thin tube from a vial shown below the antibody. The picture on the left shows the thin tube in a black square. Flash-shaped arrows (red, green) (fluorescence)point towards the right of the black square.<br />

    ILM – Optical analytics

    In collaboration with the company Labor Dr. Merk & Kollegen GmbH and the Institute of Virology at the University of Ulm, the ILM is developing an innovative detection system for the early diagnosis of influenza virus infections in pharyngeal secretions.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-optical-analytics
  • Press release - 08/01/2009 The figure shows two photos, both of them have a dark red background and light red spots; the right sides of the two photos is twice as light as the left side.<br />

    ILM – Bioactive interfaces

    It is particularly important to consider the biocompatibility of material interfaces. For example, implant materials with a surface composition that favours cell growth have a decisive advantage. However there are other cases where biophobic material characteristics might be more suitable. For example, specifically modifying the surface of surgical metals might prevent pathogens from attaching and could also make the cleaning and deactivation of…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-bioactive-interfaces

Page 99 / 119

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 119
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search